Ibotta, Inc.
NYSE:IBTASoftware - Application
-$0.19 today
- Market cap
- $1.16B
- Beta
- -0.58
- P/E (TTM)
- -96.1
- EPS (TTM)
- -$0.30
Volume 0.45M
Average 0.22M
IBTA Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Ibotta, Inc.NYSE: IBTA
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities falls 12.0% from a year ago
Other current liabilities stood at $76.48M at the end of Q1 FY2026, down 12.0% from a year earlier and down 2.7% from the prior quarter. Over 3 fiscal years it compounded at -12.6% a year.
Context
- Other current liabilities amounted to 15.9% of total assets at the end of Q1 FY2026, up 2.3 pp from a year earlier.
- Other current liabilities increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -12.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 78.58M USD
- Year-over-year change
- -16.8%
- 3-year CAGR
- -12.6%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 78.58M | -16.8% |
| FY2024 | 2024-12-31 | 94.46M | -11.7% |
| FY2023 | 2023-12-31 | 107M | -9.0% |
| FY2022 | 2022-12-31 | 117.63M | — |
Other Current Liabilities vs competitors
How IBTA compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -12.0% is the 7th highest of 8, against a peer median of +65.1%.
- Other current liabilities amounts to 15.9% of total assets for IBTA, versus a peer median of 6.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | CN¥3.04B CNY | +369.4% | +2.2% | 6.7% | |
| Mar 2026 | $93.59M USD | +65.1% | +2.6% | 11.1% | |
| Mar 2026 | $76.48M USD | -12.0% | -12.6% | 15.9% | |
| Mar 2026 | $33.47M USD | +86.2% | +1.2% | 8.9% | |
| Mar 2026 | $16.96M USD | -13.2% | -10.1% | 6.7% | |
| Mar 2026 | $12.93M USD | +16.1% | +21.4% | 8.0% | |
| Mar 2026 | $10.02M USD | +82.6% | +169.4% | 4.3% | |
| Mar 2026 | $8.38M USD | +62.9% | +8.7% | 2.5% | |
| Mar 2026 | $1.76M USD | — | — | 1.6% | |
| Mar 2026 | -$41.61M USD | — | — | 5.8% | |
| Peer median (excluding IBTA) | — | +65.1% | +2.6% | 6.7% | |
Competitors are the stored peer set for IBTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 17.82M | 62.59M | 349.28M | 186.61M |
| Short-term Investments | 27.68M | 0 | 0 | 0 |
| Net Receivables | 121.56M | 226.44M | 220.88M | 208.71M |
| Inventory | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.4M | 922K | 1.24M | 12.6M |
| Total Current Assets | 174.46M | 298.34M | 581.74M | 407.93M |
| Property, Plant & Equipment (Net) | 5.56M | 3.37M | 1.95M | 33.34M |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 8.75M | 12.84M | 16.2M | 24.19M |
| Long-term Investments | 4.53M | 4.53M | 4.53M | 4.53M |
| Tax Assets | 1.52M | 0 | 0 | 54.85M |
| Other Non-current Assets | 263K | 699K | 74.01M | 1.08M |
| Total Non-current Assets | 20.62M | 21.45M | 96.69M | 117.99M |
| Total Assets | 195.08M | 319.79M | 678.43M | 525.91M |
| Account Payables | 5.86M | 8.94M | 7.16M | 10.84M |
| Short-term Debt | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.05M | 2.63M | 4.96M | 2.94M |
| Other Current Liabilities | 117.63M | 107M | 94.46M | 78.58M |
| Total Current Liabilities | 143.9M | 198.15M | 204.17M | 207.76M |
| Long-term Debt | 61.05M | 64.45M | 0 | 25.5M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 24.93M | 29.26M | 16.98M | 5M |
| Total Non-current Liabilities | 85.98M | 93.71M | 16.98M | 30.5M |
| Total Liabilities | 229.87M | 291.86M | 221.15M | 238.26M |
| Common Stock | 0 | 0 | 0 | 0 |
| Retained Earnings | (247.31M) | (209.19M) | (140.45M) | (136.87M) |
| Accumulated OCI | (126K) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Total Equity | (34.79M) | 27.93M | 457.28M | 287.65M |
| Total Debt | 61.05M | 64.45M | 0 | 25.5M |
| Net Debt | 43.23M | 1.86M | (349.28M) | (161.11M) |
Ibotta, Inc.
NYSE:IBTA
Intrinsic Alpha fair value
Locked
Current Price
$56.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.